Alivexis and Astellas Pharma Announce Collaborative Research on New Drug Discovery Targets
Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-29
Alivexis, Inc. (Headquarters: Minato-ku, Tokyo, CEO: Shun Kimura) announced on March 26, 2026, the s… · 2026-03-29
<div class="pr-img"><figure class="pr-img__item--large"><img src="https://prcdn.freetls.fastly.net/r… · 2026-03-29
Alivexis Begins Collaborative Drug Discovery Research with Astellas Pharma · 2026-03-29